Ketogenic Diet Protects from Experimental Colitis in a Mouse Model Regardless of Dietary Fat Source
Nutrients · 2024
DOI: 10.3390/nu16091348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Lotta Luiskari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland. Hauptthemen laut MEDLINE: Diet, Ketogenic, Colitis, Mice, Inbred C57BL, Disease Models, Animal. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mary och Georg C. Ehrnrooths Stiftelse, Finnish Cultural Foundation, Finnish Concordia Fund.
Abstract (Originalsprache)
While ketogenic diets (KDs) may have potential as adjunct treatments for gastrointestinal diseases, there is little knowledge on how the fat source of these diets impacts intestinal health. The objective of this study was to investigate how the source of dietary fat of KD influences experimental colitis. We fed nine-week-old male C57BL/6J mice (n = 36) with a low-fat control diet or KD high either in saturated fatty acids (SFA-KD) or polyunsaturated linoleic acid (LA-KD) for four weeks and then induced colitis with dextran sodium sulfate (DSS). To compare the diets, we analyzed macroscopic and histological changes in the colon, intestinal permeability to fluorescein isothiocyanate−dextran (FITC–dextran), and the colonic expression of tight junction proteins and inflammatory markers. While the effects were more pronounced with LA-KD, both KDs markedly alleviated DSS-induced histological lesions. LA-KD prevented inflammation-related weight loss and the shortening of the colon, as well as preserved Il1b and Tnf expression at a healthy level. Despite no significant between-group differences in permeability to FITC–dextran, LA-KD mitigated changes in tight junction protein expression. Thus, KDs may have preventive potential against intestinal inflammation, with the level of the effect being dependent on the dietary fat source.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
- Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
- Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, 00014 Helsinki, Finland.
- Finnish Centre for Laboratory Animal Pathology, Helsinki Institute of Life Science, University of Helsinki, 00014 Helsinki, Finland.
- Folkhälsan Institute of Genetics, Folkhälsan Research Center, 00290 Helsinki, Finland.
- Department of Nephrology, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland.
ORCID-Profile: Lotta Luiskari, Jere Lindén, Markku Lehto, Hanne Salmenkari
Förderung
- Mary och Georg C. Ehrnrooths Stiftelse
- Finnish Cultural Foundation
- Finnish Concordia Fund
- Finska Läkaresällskapet
- Novo Nordisk Foundation
- Wilhelm and Else Stockmann Foundation
- Finnish Cultural Foundation’s Kymenlaakso regional fund
- Mary and Georg C. Ehrnrooth’s Foundation
Zitieren
APA
Luiskari, L., Lindén, J., Lehto, M., Salmenkari, H., & Korpela, R. (2024). Ketogenic Diet Protects from Experimental Colitis in a Mouse Model Regardless of Dietary Fat Source. Nutrients. https://doi.org/10.3390/nu16091348
Vancouver
Luiskari L, Lindén J, Lehto M, Salmenkari H, Korpela R. Ketogenic Diet Protects from Experimental Colitis in a Mouse Model Regardless of Dietary Fat Source. Nutrients. 2024. doi:10.3390/nu16091348
BibTeX
@article{Luiskari2024,
author = {Luiskari, Lotta and Lindén, Jere and Lehto, Markku and Salmenkari, Hanne and Korpela, Riitta},
title = {Ketogenic Diet Protects from Experimental Colitis in a Mouse Model Regardless of Dietary Fat Source},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16091348}
}
EUVIMED